Journal of South Asian Federation of Obstetrics and Gynaecology

Register      Login

VOLUME 14 , ISSUE 4 ( July-August, 2022 ) > List of Articles

ORIGINAL RESEARCH

An Experience with Management of COVID-19 Positive Pregnant Patients in a Tertiary Care Institute

Arun Harishchandra Nayak, Deepali Kapote

Keywords : Antibiotic, Apgar score, COVID-19, Hypothyroidism, Multigravida, Multivitamin, Pandemic, Pneumonia, RT-PCR

Citation Information : Nayak AH, Kapote D. An Experience with Management of COVID-19 Positive Pregnant Patients in a Tertiary Care Institute. J South Asian Feder Obs Gynae 2022; 14 (4):424-428.

DOI: 10.5005/jp-journals-10006-2083

License: CC BY-NC 4.0

Published Online: 22-08-2022

Copyright Statement:  Copyright © 2022; The Author(s).


Abstract

Background: The new coronavirus disease 2019 (COVID-19) is a worldwide pandemic. Concerns have been raised about the influence of SARS-CoV-2 infections on pregnant mothers and their fetuses, and patient care in the setting of COVID-19 is difficult. As a result, the current study was conducted to determine the outcomes of pregnant females with COVID-19 infection and their obstetric care of COVID-19. Materials and methods: The study enrolled 8622 pregnant women from April 1st, 2020 to September 30th, 2020 at Lokmanya Tilak Medical College and Sion Hospital, a tertiary care hospital. There were 455 women who tested positive for COVID, whereas the remaining 8167 patients tested negative for COVID. The results obtained were compared in both groups. Results: The percentage of pregnant women who tested positive for COVID was determined to be 5.27%. Most patients were delivered by LSCS in the COVID-positive group (49.45%) than in the COVID-negative group (43.95%) (p >0.05). Among 455 COVID-positive women, 401 were asymptomatic, whereas 54 patients showed COVID-19 symptoms like fever and cough (12%). All patients with mild symptoms were adequately handled with a multivitamin supplement, high-protein diet, fluid-electrolyte balance, regular vitals monitoring, and prophylactic antibiotic therapy. In total, 23 women were admitted to the intensive care unit after developing severe COVID-19 pneumonia with ARDS. The risk of maternal mortality in COVID-positive patients was somewhat higher 16 (3.51%) than in COVID-negative pregnant women 39 (0.47%) (p <0.05). In the majority of neonates in both the COVID-positive and -negative women, Apgar score was normal 7–10, and birth weight between 2.6 and 3 kg. Low Apgar scores (0–3) were seen in 6 (1.43%) of COVID-positive mothers’ neonates and 197 (2.60%) of COVID-negative mothers’ neonates. Overall, the majority of the newborns were healthy. Swabs from seven neonates were first determined to be positive, but were retested on day five and proved to be negative. Conclusions: In times of global pandemic, quick and judicious management of COVID-19 positive pregnant women is a critical notion for safe motherhood and healthy children. However, our findings reveal that COVID infection has no substantial influence on maternal and fetal outcomes in pregnancy, and there is no indication of vertical transmission of the COVID-19 infection, but long-term monitoring of these newborns is suggested.


PDF Share
  1. Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med 2020;382(13):1199–1207. DOI: 10.1056/NEJMoa2001316.
  2. Mehta AV, Patel RV, Shah PT, et al. COVID-19 infection in reproductive age group females: experience of a tertiary care urban teaching hospital. J Obstet Gynaecol India 2021;71(Suppl 1):1–5. DOI: 10.1007/s13224-021-01519-5.
  3. Goyal M, Singh P, Singh K, et al. The effect of the COVID-19 pandemic on maternal health due to delay in seeking health care: experience from a tertiary center. Int J Gynecol Obstet 2021;152(2):231–235. DOI:10.1002/ijgo.13457.
  4. Ellington S, Strid P, Tong VT, et al. Characteristics of women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status—United States, January 22-June 7, 2020. MMWR Morb Mortal Wkly Rep 2020;69(25):769–775.
  5. Hanna N, Hanna M, Sharma S. Is pregnancy an immunological contributor to severe or controlled COVID-19 disease? Am J Reprod Immunol 2020;84(5):e13317. DOI: 10.1111/aji.13317.
  6. Dashraath P, Wong JLJ, Lim MXK, et al. Coronavirus disease 2019 (COVID-19) pandemic and pregnancy. Am J Obstet Gynecol 2020;222(6):521–531. DOI: 10.1016/j.ajog.2020.03.021.
  7. Al-Tawfiq JA. Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and COVID-19 infection during pregnancy. Travel Med Infect Dis 2020. Available at: https://www.ncbi.nlm.nih.gov/pmc/artic les/PMC71 18624 [Accessed on May 26, 2020].
  8. Mei Y, Luo D, Wei S, et al. Obstetric management of COVID-19 in pregnant women. Front Microbiol 2020;11:1186. DOI: 10.3389/fmicb.2020.01186.
  9. Nayak AH, Kapote DS, Fonseca M, et al. Impact of Coronavirus infection in pregnancy: a preliminary study of 141 patient. J Obstet Gynaecol India 2020;70(4):256–261. DOI: 10.1007/s13224-020-01335-3.
  10. López M, Gonce A, Meler E, et al. Coronavirus disease 2019 in pregnancy: a clinical management protocol and considerations for practice. Fetal Diagn Ther 2020;47(7):519–528. DOI: 10.1159/000508487.
  11. Adhikari EH, Moreno W, Zofkie AC, et al. Pregnancy outcomes among women with and without severe acute respiratory syndrome Coronavirus 2 infection. JAMA Netw Open 2020;3(11):e2029256. DOI: 10.1001/jamanetworkopen.2020.29256.
  12. Chen H, Guo J, Wang C, et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet 2020;395(10226):809–815.
  13. Naseer S, Andrabi SU, Andrabi SI, et al. Management of pregnant women in times of COVID-19 our experience from Kashmir valley. Int J Reprod Contracept Obstet Gynecol 2021;10(4):1379–1383. DOI: 10.18203/2320-1770.ijrcog20210988.
  14. Chen L, Li Q, Zheng D, et al. Clinical characteristics of pregnant women with COVID-19 in Wuhan, China. N Engl J Med 2020;382(25):e100. DOI: 10.1056/NEJMc2009226.
  15. Zhao RH, Wang H, Xu KJ, et al. Pregnancy with 2019 novel Coronavirus: a case report. Zhejiang Med J 2020;42:303–317. DOI: 10.12056/j.issn.1006-2785.2020.42.3.2020-237.
  16. Di Mascio D, Khalil A, Saccone G, et al. Outcome of coronavirus spectrum infections (SARS, MERS, COVID-19) during pregnancy: a systematic review and meta-analysis. Am J Obstet Gynecol MFM 2020;2(2):100107. DOI: 10.1016/j.ajogmf.2020.100107.
  17. Zhu H, Wang L, Fang C, et al. Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia. Transl Pediatr 2020;9(1):51–60. DOI: 10.21037/tp.2020.02.06.
  18. WAPM Working Group on COVID. Maternal and perinatal outcomes of pregnant women with SARS-COV-2 infection. Ultrasound Obstet Gynecol 2021;57(2):232–241. DOI: 10.1002/uog.23107.
  19. Alzamora MC, Paredes T, Caceres D, et al. Severe COVID-19 during pregnancy and possible vertical transmission. Am J Perinatol 2020;37(8):861–865. DOI: 10.1055/s-0040-1710050.
  20. Mendoza M, Garcia-Ruiz I, Maiz N, et al. Pre-eclampsia-like syndrome induced by severe COVID-19: a prospective observational study. BJOG 2020;127(11):1374–1380. DOI: 10.1111/1471-0528.16339.
  21. Karimi-Zarchi M, Neamatzadeh H, Dastgheib SA, et al. Vertical transmission of Coronavirus disease 19 (COVID-19) from infected pregnant mothers to neonates: a review. Fetal Pediatr Pathol 2020;39(3):246–250. DOI: 10.1080/15513815.2020.1747120.
  22. WHO. Summary of Probable SARS Cases with Onset of Illness from 1 November 2002 to 31 July 2003. Available at: https://www.who.int/csr/sars/country/table2004_04_21/en/ [Accessed on April 16, 2020].
  23. Villar J, Ariff S, Gunier RB, et al. Maternal and neonatal morbidity and mortality among pregnant women with and without COVID-19 infection: The INTERCOVID Multinational Cohort Study. JAMA Pediatr 2021;175(8):817–826. DOI: 10.1001/jamapediatrics.2021.1050.
  24. Metz TD, Clifton RG, Hughes BL, et al. Disease severity and perinatal outcomes of pregnant patients with Coronavirus disease 2019 (COVID-19). Obstet Gynecol 2021;137(4):571–580. DOI: 10.1097/AOG.0000000000004339.
  25. Zheng Q-L, Duan T, Jin L-P. Single-cell RNA expression profiling of ACE2 and AXL in the human maternal–fetal interface. Reprod Dev Med 2020;4(1):7–10. DOI: 10.4103/2096-2924.278679.
  26. Zhou J, Li C, Zhao G, et al. Human intestinal tract serves as an alternative infection route for Middle East respiratory syndrome coronavirus. Sci Adv 2017;3(11):eaao4966. DOI: 10.1126/sciadv.aao4966.
  27. National Health Commission of the People's Republic of China. The Notice of Launching Guideline on Diagnosis and Treatment of the Novel Coronavirus Pneumonia (NCP) 2020. Available online at: http://www.nhc.gov.cn/yzygj/s7653p/202003/46c9294a7dfe4cef80dc7f5912eb1989.shtml [Accessed on March 3, 2020].
  28. WHO. Clinical Management of Severe Acute Respiratory Infection when COVID-19 is Suspected. Available at: www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus- (ncov)-infection-is-suspected [Accessed on April 15, 2020].
  29. CDC. Coronavirus Disease (COVID-19) and Breastfeeding. Available at: www.cdc.gov/breastfeeding/breastfeeding-special-circumstances/maternal-or-infant-illnesses/covid19-and-breastfeeding.html [Accessed on April 15, 2020].
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.